High Profile Publications

Home › Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial

Switch to long-acting cabotegravir and rilpivirine in virologically suppressed adults with HIV in Africa (CARES): week 48 results from a randomised, multicentre, open-label, non-inferiority trial

Authors: Cissy Kityo, Ivan K Mambule, Joseph Musaazi, Simiso Sokhela, Henry Mugerwa, Gilbert Ategeka, Fiona Cresswell, Abraham Siika, Josphat Kosgei, Reena Shah, Logashvari Naidoo, Kimton Opiyo, Caroline Otike, Karlien Möller, Arvind Kaimal, Charity Wambui, Veerle Van Eygen, Perry Mohammed, Fafa Addo Boateng, Nicholas I Paton*; CARES trial team

Journal: The Lancet. Infectious diseases.2024 May 28:S1473-3099(24)00289-5.

DOI: 10.1016/S1473-3099(24)00289-5

Notable Achievements

High Profile Publications

Impact of CD151 overexpression on prognosis and therapy in non-small cell lung cancer patients lacking EGFR mutations

Authors: Amanda Huee-Ping Wong, Min En Nga, Chin Yein Chin, …

High Profile Publications

Single-shot dendritic cell targeting SARS-CoV-2 vaccine candidate induces broad, durable and protective systemic and mucosal immunity in mice

Authors: Nicholas You Zhi Cheang, Kai Sen Tan, Peck Szee …

High Profile Publications

Enterovirus-A71 exploits RAB11 to recruit chaperones for virus morphogenesis

Authors: Qing Yong Ng, Vikneswari Mahendran, Ze Qin Lim, Jasmine …

Infectious Diseases Translational Research Programme

© National University of Singapore. All Rights Reserved.